アルツハイマー病治療薬の世界市場 2021年:メーカー別、地域別、種類・用途別

◆英語タイトル:Global Alzheimer’s Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21AR00798
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年4月
◆ページ数:102
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥382,800見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥574,200見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥765,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalInfoResearch社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

GlobalInfoResearch社の本調査レポートでは、アルツハイマー病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。アルツハイマー病治療薬の種類別市場規模(コリン作動性、メマンチン、併用薬)、用途別市場規模(病院薬局、小売薬局、オンライン販売)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Ono Pharmaceutical、Johnson & Johnson、Daiichi Sankyo Company Limited、H Lundbeck A/S、Eisai Co Ltd.
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:コリン作動性、メマンチン、併用薬
・用途別分析2016年-2026年:病院薬局、小売薬局、オンライン販売
・アルツハイマー病治療薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・アルツハイマー病治療薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・アルツハイマー病治療薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・アルツハイマー病治療薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・アルツハイマー病治療薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Alzheimer’s Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Alzheimer’s Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Alzheimer’s Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Alzheimer’s Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Cholinergic
Memantine
CombinedDrug

Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Sales

The key market players for global Alzheimer’s Drugs market are listed below:
Ono Pharmaceutical
Johnson & Johnson
Daiichi Sankyo Company Limited
H Lundbeck A/S
Eisai Co Ltd.

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Alzheimer’s Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alzheimer’s Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Cholinergic
1.2.3 Memantine
1.2.4 CombinedDrug
1.3 Market Analysis by Application
1.3.1 Overview: Global Alzheimer’s Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.4 Global Alzheimer’s Drugs Market Size & Forecast
1.4.1 Global Alzheimer’s Drugs Sales in Value (2016-2026))
1.4.2 Global Alzheimer’s Drugs Sales in Volume (2016-2026)
1.4.3 Global Alzheimer’s Drugs Price by Type (2016-2026) & (US$/Unit)
1.5 Global Alzheimer’s Drugs Production Capacity Analysis
1.5.1 Global Alzheimer’s Drugs Total Production Capacity (2016-2026)
1.5.2 Global Alzheimer’s Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Alzheimer’s Drugs Market Drivers
1.6.2 Alzheimer’s Drugs Market Restraints
1.6.3 Alzheimer’s Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Ono Pharmaceutical
2.1.1 Ono Pharmaceutical Details
2.1.2 Ono Pharmaceutical Major Business
2.1.3 Ono Pharmaceutical Alzheimer’s Drugs Product and Services
2.1.4 Ono Pharmaceutical Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Alzheimer’s Drugs Product and Services
2.2.4 Johnson & Johnson Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Daiichi Sankyo Company Limited
2.3.1 Daiichi Sankyo Company Limited Details
2.3.2 Daiichi Sankyo Company Limited Major Business
2.3.3 Daiichi Sankyo Company Limited Alzheimer’s Drugs Product and Services
2.3.4 Daiichi Sankyo Company Limited Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 H Lundbeck A/S
2.4.1 H Lundbeck A/S Details
2.4.2 H Lundbeck A/S Major Business
2.4.3 H Lundbeck A/S Alzheimer’s Drugs Product and Services
2.4.4 H Lundbeck A/S Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Eisai Co Ltd.
2.5.1 Eisai Co Ltd. Details
2.5.2 Eisai Co Ltd. Major Business
2.5.3 Eisai Co Ltd. Alzheimer’s Drugs Product and Services
2.5.4 Eisai Co Ltd. Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Alzheimer’s Drugs Sales by Manufacturer
3.1 Global Alzheimer’s Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Alzheimer’s Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Alzheimer’s Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Alzheimer’s Drugs Manufacturer Market Share
3.4.2 Top 6 Alzheimer’s Drugs Manufacturer Market Share
3.5 Global Alzheimer’s Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Alzheimer’s Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Alzheimer’s Drugs Market Size by Region
4.1.1 Global Alzheimer’s Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Alzheimer’s Drugs Revenue by Region (2016-2026)
4.2 North America Alzheimer’s Drugs Revenue (2016-2026)
4.3 Europe Alzheimer’s Drugs Revenue (2016-2026)
4.4 Asia-Pacific Alzheimer’s Drugs Revenue (2016-2026)
4.5 South America Alzheimer’s Drugs Revenue (2016-2026)
4.6 Middle East and Africa Alzheimer’s Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Alzheimer’s Drugs Sales in Volume by Type (2016-2026)
5.2 Global Alzheimer’s Drugs Revenue by Type (2016-2026)
5.3 Global Alzheimer’s Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Alzheimer’s Drugs Sales in Volume by Application (2016-2026)
6.2 Global Alzheimer’s Drugs Revenue by Application (2016-2026)
6.3 Global Alzheimer’s Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Alzheimer’s Drugs Sales by Type (2016-2026)
7.2 North America Alzheimer’s Drugs Sales by Application (2016-2026)
7.3 North America Alzheimer’s Drugs Market Size by Country
7.3.1 North America Alzheimer’s Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Alzheimer’s Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Alzheimer’s Drugs Sales by Type (2016-2026)
8.2 Europe Alzheimer’s Drugs Sales by Application (2016-2026)
8.3 Europe Alzheimer’s Drugs Market Size by Country
8.3.1 Europe Alzheimer’s Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Alzheimer’s Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Alzheimer’s Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Alzheimer’s Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Alzheimer’s Drugs Market Size by Region
9.3.1 Asia-Pacific Alzheimer’s Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Alzheimer’s Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Alzheimer’s Drugs Sales by Type (2016-2026)
10.2 South America Alzheimer’s Drugs Sales by Application (2016-2026)
10.3 South America Alzheimer’s Drugs Market Size by Country
10.3.1 South America Alzheimer’s Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Alzheimer’s Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Alzheimer’s Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Alzheimer’s Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Alzheimer’s Drugs Market Size by Country
11.3.1 Middle East & Africa Alzheimer’s Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Alzheimer’s Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Alzheimer’s Drugs Typical Distributors
12.3 Alzheimer’s Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Alzheimer’s Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Alzheimer’s Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Ono Pharmaceutical Major Business
Table 5. Ono Pharmaceutical Alzheimer’s Drugs Product and Services
Table 6. Ono Pharmaceutical Alzheimer’s Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Alzheimer’s Drugs Product and Services
Table 10. Johnson & Johnson Alzheimer’s Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Daiichi Sankyo Company Limited Basic Information, Manufacturing Base and Competitors
Table 12. Daiichi Sankyo Company Limited Major Business
Table 13. Daiichi Sankyo Company Limited Alzheimer’s Drugs Product and Services
Table 14. Daiichi Sankyo Company Limited Alzheimer’s Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. H Lundbeck A/S Basic Information, Manufacturing Base and Competitors
Table 16. H Lundbeck A/S Major Business
Table 17. H Lundbeck A/S Alzheimer’s Drugs Product and Services
Table 18. H Lundbeck A/S Alzheimer’s Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eisai Co Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. Eisai Co Ltd. Major Business
Table 21. Eisai Co Ltd. Alzheimer’s Drugs Product and Services
Table 22. Eisai Co Ltd. Alzheimer’s Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Alzheimer’s Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global Alzheimer’s Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Alzheimer’s Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Alzheimer’s Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Alzheimer’s Drugs Production Site of Key Manufacturer
Table 28. Global Alzheimer’s Drugs Sales by Region (2016-2021e) & (K Units)
Table 29. Global Alzheimer’s Drugs Sales by Region (2021-2026) & (K Units)
Table 30. Global Alzheimer’s Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Alzheimer’s Drugs Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Alzheimer’s Drugs Sales by Type (2016-2021e) & (K Units)
Table 33. Global Alzheimer’s Drugs Sales by Type (2021-2026) & (K Units)
Table 34. Global Alzheimer’s Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Alzheimer’s Drugs Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Alzheimer’s Drugs Price by Type (2016-2021e) & (US$/Unit)
Table 37. Global Alzheimer’s Drugs Price by Type (2021-2026) & (US$/Unit)
Table 38. Global Alzheimer’s Drugs Sales by Application (2016-2021e) & (K Units)
Table 39. Global Alzheimer’s Drugs Sales by Application (2021-2026) & (K Units)
Table 40. Global Alzheimer’s Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Alzheimer’s Drugs Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Alzheimer’s Drugs Price by Application (2016-2021e) & (US$/Unit)
Table 43. Global Alzheimer’s Drugs Price by Application (2021-2026) & (US$/Unit)
Table 44. North America Alzheimer’s Drugs Sales by Country (2016-2021e) & (K Units)
Table 45. North America Alzheimer’s Drugs Sales by Country (2021-2026) & (K Units)
Table 46. North America Alzheimer’s Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Alzheimer’s Drugs Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Alzheimer’s Drugs Sales by Type (2016-2021e) & (K Units)
Table 49. North America Alzheimer’s Drugs Sales by Type (2021-2026) & (K Units)
Table 50. North America Alzheimer’s Drugs Sales by Application (2016-2021e) & (K Units)
Table 51. North America Alzheimer’s Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Europe Alzheimer’s Drugs Sales by Country (2016-2021e) & (K Units)
Table 53. Europe Alzheimer’s Drugs Sales by Country (2021-2026) & (K Units)
Table 54. Europe Alzheimer’s Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Alzheimer’s Drugs Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Alzheimer’s Drugs Sales by Type (2016-2021e) & (K Units)
Table 57. Europe Alzheimer’s Drugs Sales by Type (2021-2026) & (K Units)
Table 58. Europe Alzheimer’s Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. Europe Alzheimer’s Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Asia-Pacific Alzheimer’s Drugs Sales by Region (2016-2021e) & (K Units)
Table 61. Asia-Pacific Alzheimer’s Drugs Sales by Region (2021-2026) & (K Units)
Table 62. Asia-Pacific Alzheimer’s Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Alzheimer’s Drugs Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Alzheimer’s Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Asia-Pacific Alzheimer’s Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Asia-Pacific Alzheimer’s Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. Asia-Pacific Alzheimer’s Drugs Sales by Application (2021-2026) & (K Units)
Table 68. South America Alzheimer’s Drugs Sales by Country (2016-2021e) & (K Units)
Table 69. South America Alzheimer’s Drugs Sales by Country (2021-2026) & (K Units)
Table 70. South America Alzheimer’s Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Alzheimer’s Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Alzheimer’s Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. South America Alzheimer’s Drugs Sales by Type (2021-2026) & (K Units)
Table 74. South America Alzheimer’s Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. South America Alzheimer’s Drugs Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Alzheimer’s Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. Middle East & Africa Alzheimer’s Drugs Sales by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Alzheimer’s Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Alzheimer’s Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Alzheimer’s Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. Middle East & Africa Alzheimer’s Drugs Sales by Type (2021-2026) & (K Units)
Table 82. Middle East & Africa Alzheimer’s Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. Middle East & Africa Alzheimer’s Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Alzheimer’s Drugs Typical Distributors
Table 87. Alzheimer’s Drugs Typical Customers
List of Figures
Figure 1. Alzheimer’s Drugs Picture
Figure 2. Global Alzheimer’s Drugs Sales Market Share by Type in 2020
Figure 3. Cholinergic
Figure 4. Memantine
Figure 5. CombinedDrug
Figure 6. Global Alzheimer’s Drugs Sales Market Share by Application in 2020
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Online Sales
Figure 10. Global Alzheimer’s Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Alzheimer’s Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Alzheimer’s Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Alzheimer’s Drugs Sales (2016-2026) & (K Units)
Figure 32. Global Alzheimer’s Drugs Production Capacity (2016-2026) & (K Units)
Figure 33. Global Alzheimer’s Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Alzheimer’s Drugs Market Drivers
Figure 35. Alzheimer’s Drugs Market Restraints
Figure 36. Alzheimer’s Drugs Market Trends
Figure 37. Global Alzheimer’s Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Alzheimer’s Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Alzheimer’s Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Alzheimer’s Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Alzheimer’s Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Alzheimer’s Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Alzheimer’s Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Alzheimer’s Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Alzheimer’s Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Alzheimer’s Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Alzheimer’s Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Alzheimer’s Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Alzheimer’s Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Alzheimer’s Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Alzheimer’s Drugs Price by Type (2016-2026) & (US$/Unit)
Figure 52. Global Alzheimer’s Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Alzheimer’s Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Alzheimer’s Drugs Price by Application (2016-2026) & (US$/Unit)
Figure 55. North America Alzheimer’s Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Alzheimer’s Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Alzheimer’s Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Alzheimer’s Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Alzheimer’s Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Alzheimer’s Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Alzheimer’s Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Alzheimer’s Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Alzheimer’s Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Alzheimer’s Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Alzheimer’s Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Alzheimer’s Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Alzheimer’s Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Alzheimer’s Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Alzheimer’s Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Alzheimer’s Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Alzheimer’s Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Alzheimer’s Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Alzheimer’s Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Alzheimer’s Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source


【掲載企業】

Ono Pharmaceutical、Johnson & Johnson、Daiichi Sankyo Company Limited、H Lundbeck A/S、Eisai Co Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アルツハイマー病治療薬の世界市場 2021年:メーカー別、地域別、種類・用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆